Abstract

Abstract In 51 hospitals in six European countries 713 patients requiring below–knee amputation for ischaemic disease were studied prospectively. The patients were allocated randomly to receive standard postoperative treatment or standard treatment plus intravenous infusion of the prostacyclin analogue iloprost for 6 h per day over 14–21 days. Healing of the amputation stump and the need for reamputation at a higher level were similar in the two groups. Overall at 3 months 59 per cent of stumps had healed, 19 per cent of patients had required reamputation at a higher level, 11 per cent had died and the remaining 11 per cent remained with unhealed stumps. Preoperative characteristics were analysed as possible risk factors or markers for primary healing, reamputation and death. Previous arterial reopening procedures (surgical or radiological) almost doubled the chances of primary stump healing (P<0–05). The surgeon's assessment of the likelihood of healing was wrong in 21 per cent of cases in which the operating surgeon thought that healing would probably occur and in 52 per cent of those in which it was thought healing was improbable.

Keywords

MedicineProstacyclinAmputationIschemiaIloprostProspective cohort studySurgeryInternal medicine

MeSH Terms

AdultAgedAged80 and overAmputationSurgicalFemaleHumansIloprostInfusionsIntravenousIschemiaLegMaleMiddle AgedPrognosisProspective StudiesReoperationRisk FactorsWound Healing

Affiliated Institutions

Related Publications

Publication Info

Year
1994
Type
article
Volume
81
Issue
1
Pages
33-37
Citations
93
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

93
OpenAlex
4
Influential
65
CrossRef

Cite This

John Dormandy, G Belcher, Paul Broos et al. (1994). Prospective study of 713 below–knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. British journal of surgery , 81 (1) , 33-37. https://doi.org/10.1002/bjs.1800810110

Identifiers

DOI
10.1002/bjs.1800810110
PMID
7508804

Data Quality

Data completeness: 81%